Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mucopolysaccharidosis I (MPS I) Registry

NCT00144794 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00144794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mucopolysaccharidosis I (MPS I) Registry
Lead sponsor
Genzyme, a Sanofi Company
Phase
Observational
Overall status
Completed
Start date
November 20, 2003
Completion date
December 31, 2024
Enrollment
1,406 (actual)
Sites
141

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis i (mps i)